{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih2zj2cyefaupnhtpzz6trmc3v6xkuctovu2abbalmv3wjftvabxe",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mp3wnvkxfgs2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/06/24/fda-commissioner-candidate-germany-plans-for-drug-prices/?utm_campaign=rss",
  "publishedAt": "2026-06-24T13:00:37.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "Regenxbio plans to apply for accelerated approval for its gene therapy for Duchenne muscular dystrophy.",
  "title": "STAT+: Pharmalittle: We’re reading about an FDA commissioner candidate, Germany’s plans for drug prices, and more",
  "updatedAt": "2026-06-24T13:00:42.000Z"
}